Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15126500 | Publishing Date : 27-Jan-2020 | No. of pages : 98
Detailed TOC of Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hormones and Antagonists
1.4.3 Microorganism Products
1.4.4 Plant Products
1.4.5 Antitumor Antibiotics
1.4.6 Alkylating Agents
1.4.7 Antimetabolites
1.4.8 Natural Products
1.5 Market by Application
1.5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026
1.5.2 Lung Cancer
1.5.3 Bladder Cancer
1.5.4 Breast Cancer
1.5.5 Cervical Cancer
1.5.6 Leukemia
1.5.7 Gynecological Cancer
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Anti-Neoplastic Pharmaceutical Agents Market Perspective (2015-2026)
2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions
2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Share by Regions (2015-2020)
2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy
2.3.6 Primary Interviews with Key Anti-Neoplastic Pharmaceutical Agents Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Market Size
3.1.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue (2015-2020)
3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2015-2020)
3.1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio
3.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019
3.3 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served
3.4 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
3.5 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2015-2020)
4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2021-2026)
5 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Application (2015-2026)
5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
6.2 Anti-Neoplastic Pharmaceutical Agents Key Players in North America (2019-2020)
6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
7 Europe
7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
7.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Europe (2019-2020)
7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
8 China
8.1 China Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
8.2 Anti-Neoplastic Pharmaceutical Agents Key Players in China (2019-2020)
8.3 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
8.4 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
9 Japan
9.1 Japan Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
9.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Japan (2019-2020)
9.3 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
9.4 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
10.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
11 India
11.1 India Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
11.2 Anti-Neoplastic Pharmaceutical Agents Key Players in India (2019-2020)
11.3 India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
11.4 India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020)
12.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020)
12.4 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020)
13Key Players Profiles
13.1 GlaxoSmithKline plc.
13.1.1 GlaxoSmithKline plc. Company Details
13.1.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction
13.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020))
13.1.5 GlaxoSmithKline plc. Recent Development
13.2 F. Hoffmann-La Roche Ltd
13.2.1 F. Hoffmann-La Roche Ltd Company Details
13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
13.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction
13.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Ltd Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Details
13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
13.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.4.5 Bristol-Myers Squibb Company Recent Development
13.5 Becton, Dickinson and Company
13.5.1 Becton, Dickinson and Company Company Details
13.5.2 Becton, Dickinson and Company Business Overview and Its Total Revenue
13.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction
13.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.5.5 Becton, Dickinson and Company Recent Development
13.6 Pfizer Inc.
13.6.1 Pfizer Inc. Company Details
13.6.2 Pfizer Inc. Business Overview and Its Total Revenue
13.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction
13.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.6.5 Pfizer Inc. Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview and Its Total Revenue
13.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction
13.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview and Its Total Revenue
13.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction
13.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Gilead
13.9.1 Gilead Company Details
13.9.2 Gilead Business Overview and Its Total Revenue
13.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction
13.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
13.9.5 Gilead Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Anti-Neoplastic Pharmaceutical Agents Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue
Table 3. Ranking of Global Top Anti-Neoplastic Pharmaceutical Agents Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hormones and Antagonists
Table 6. Key Players of Microorganism Products
Table 7. Key Players of Plant Products
Table 8. Key Players of Antitumor Antibiotics
Table 9. Key Players of Alkylating Agents
Table 10. Key Players of Antimetabolites
Table 11. Key Players of Natural Products
Table 12. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2015-2020)
Table 16. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy
Table 22. Main Points Interviewed from Key Anti-Neoplastic Pharmaceutical Agents Players
Table 23. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2015-2020) (Million US$)
Table 24. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players (2015-2020)
Table 25. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019)
Table 26. Global Anti-Neoplastic Pharmaceutical Agents by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service
Table 29. Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 32. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Type (2015-2020)
Table 33. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2021-2026)
Table 34. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2015-2020)
Table 35. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 36. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2021-2026)
Table 37. North America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 39. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 40. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 41. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 42. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 43. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 45. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 47. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 49. China Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 50. China Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 51. China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 52. China Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 53. China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 54. China Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 55. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 57. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 59. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 63. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 65. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 67. India Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 68. India Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 69. India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 70. India Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 71. India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 72. India Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020)
Table 75. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020)
Table 77. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020)
Table 79. GlaxoSmithKline plc. Company Details
Table 80. GlaxoSmithKline plc. Business Overview
Table 81. GlaxoSmithKline plc. Product
Table 82. GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline plc. Recent Development
Table 84. F. Hoffmann-La Roche Ltd Company Details
Table 85. F. Hoffmann-La Roche Ltd Business Overview
Table 86. F. Hoffmann-La Roche Ltd Product
Table 87. F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 88. F. Hoffmann-La Roche Ltd Recent Development
Table 89. Eli Lilly and Company Company Details
Table 90. Eli Lilly and Company Business Overview
Table 91. Eli Lilly and Company Product
Table 92. Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 93. Eli Lilly and Company Recent Development
Table 94. Bristol-Myers Squibb Company Company Details
Table 95. Bristol-Myers Squibb Company Business Overview
Table 96. Bristol-Myers Squibb Company Product
Table 97. Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 98. Bristol-Myers Squibb Company Recent Development
Table 99. Becton, Dickinson and Company Company Details
Table 100. Becton, Dickinson and Company Business Overview
Table 101. Becton, Dickinson and Company Product
Table 102. Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 103. Becton, Dickinson and Company Recent Development
Table 104. Pfizer Inc. Company Details
Table 105. Pfizer Inc. Business Overview
Table 106. Pfizer Inc. Product
Table 107. Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 108. Pfizer Inc. Recent Development
Table 109. Novartis AG Company Details
Table 110. Novartis AG Business Overview
Table 111. Novartis AG Product
Table 112. Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 113. Novartis AG Recent Development
Table 114. AstraZeneca Business Overview
Table 115. AstraZeneca Product
Table 116. AstraZeneca Company Details
Table 117. AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 118. AstraZeneca Recent Development
Table 119. Gilead Company Details
Table 120. Gilead Business Overview
Table 121. Gilead Product
Table 122. Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$)
Table 123. Gilead Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type: 2020 VS 2026
Figure 2. Hormones and Antagonists Features
Figure 3. Microorganism Products Features
Figure 4. Plant Products Features
Figure 5. Antitumor Antibiotics Features
Figure 6. Alkylating Agents Features
Figure 7. Antimetabolites Features
Figure 8. Natural Products Features
Figure 9. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026
Figure 10. Lung Cancer Case Studies
Figure 11. Bladder Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Cervical Cancer Case Studies
Figure 14. Leukemia Case Studies
Figure 15. Gynecological Cancer Case Studies
Figure 16. Other Case Studies
Figure 17. Anti-Neoplastic Pharmaceutical Agents Report Years Considered
Figure 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions: 2020 VS 2026
Figure 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players in 2019
Figure 23. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019
Figure 25. North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline plc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 34. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 36. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 38. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bristol-Myers Squibb Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 40. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Becton, Dickinson and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 42. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 44. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Novartis AG Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 46. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. AstraZeneca Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 48. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Gilead Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Keyplayers in Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2020-2026
GlaxoSmithKline plc.F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol-Myers Squibb Company
Becton, Dickinson and Company
Pfizer Inc.
Novartis AG
AstraZeneca
Gilead